|
Sislaf 2,5 mg tbl flm 28x1x2,5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 2,5 mg tbl flm 28x2,5 mg (blis.PVC/PVDC/Al)
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 2,5 mg tbl flm 56x1x2,5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 2,5 mg tbl flm 56x2,5 mg (blis.PVC/PVDC/Al)
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 2,5 mg tbl flm 60x1x2,5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 2,5 mg tbl flm 60x2,5 mg (blis.PVC/PVDC/Al)
2,5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 168x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 168x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 20x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 20x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 28x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 28x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 30x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 30x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 56x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 56x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 60x1x5 mg (blis.PVC/PVDC/Al) - jednotk.bal.
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Sislaf 5 mg tbl flm 60x5 mg (blis.PVC/PVDC/Al)
5 mg
|
Filmom obalená tableta |
B01AF02
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
STADAPYRIN 100 mg tbl ent 100x100 mg (blis.PVC/Al)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|
|
STADAPYRIN 100 mg tbl ent 100x100 mg (obal HDPE)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|
|
STADAPYRIN 100 mg tbl ent 100x100 mg (obal LDPE)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|
|
STADAPYRIN 100 mg tbl ent 10x100 mg (blis.PVC/Al)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|
|
STADAPYRIN 100 mg tbl ent 10x100 mg (obal HDPE)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|
|
STADAPYRIN 100 mg tbl ent 10x100 mg (obal LDPE)
100 mg
|
Gastrorezistentná tableta |
B01AC06
|
STADA Arzneimittel AG |
—
|